Evidence map›Paper›PMID 27602078›Full record

ArticleExperimental and therapeutic medicine2016

Immunoprotection of recombinant Eg.myophilin against

Mingxing Zhu, Fu Gao, Zihua Li, Xiuqing Wang, Hao Wang, Zhisheng Wang, Jiaqing Zhao, Wei Zhao

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental and therapeutic medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Mingxing ZhuCenter of Scientific Technology, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China; Key Laboratory of Hydatid Disease, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Fu GaoInstitute of Clinical Laboratory, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China; Xi'an Traditional Chinese Medicine Hospital, Xi'an, Shannxi 710021, P.R. China.
Zihua LiCenter of Scientific Technology, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China; Key Laboratory of Hydatid Disease, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Xiuqing WangInstitute of Clinical Laboratory, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Hao WangKey Laboratory of Hydatid Disease, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China; Department of Pathogenic Biology and Medical Immunology, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Zhisheng WangExperimental Animal Center, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Jiaqing ZhaoKey Laboratory of Hydatid Disease, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China; Department of Pathogenic Biology and Medical Immunology, School of Basic Medical Sciences, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Wei ZhaoCenter of Scientific Technology, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China; Key Laboratory of Hydatid Disease, Ningxia Medical University, Yinchuan, Ningxia 750004, P.R. China.
Ningxia Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aims of the present study were to investigate the immunoprotection of recombinant

Indexed as

Echinococcus granulosusrecombinant Eg.myophilinsheepvaccine

Identifiers

PMID27602078
PMCPMC4998173
OpenAlexW2468157481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.